We are proud to announce the launch of the Nevus Owners Outcomes Registry (NOOR). NOOR creates a global platform for individuals and families affected by congenital melanocytic nevi (CMN) to strengthen their voices and share their experiences. CMN—also known as congenital nevi or birthmark moles—can be associated with complications such as neurocutaneous melanocytosis (NCM), melanoma risk, and significant psychosocial impact, and currently has no cure.

Designed with input from both scientists and patients, this global registry will collect real-world data to help researchers better understand CMN, advance treatment options, and improve care for those affected.

Join NOOR today and let your data tell your story.